20-F
Annual Report (Foreign)
Aesthetic Medical International Holdings Group Limited PAIYY
0001410578-25-000920
- Filed
- Apr 25, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2024 · Dec 31, 2024 | 143.5M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 131.66M sh |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 81.91M sh |
| Shares Outstanding | FY 2024 · Dec 31, 2024 | 147.33M sh |
| Operating Cash Flow | FY 2024 · Dec 31, 2024 | ¥79.67M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | ¥74.29M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −¥75.13M |
| Cash And Equivalents | FY 2024 · Dec 31, 2024 | ¥42.84M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | ¥62.34M |
| Stockholders Equity | FY 2024 · Dec 31, 2024 | ¥9.35M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | ¥33.63M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | −¥125.88M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | −¥186.42M |
| Current Liabilities | FY 2024 · Dec 31, 2024 | ¥402.04M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | ¥411.38M |
| Total Liabilities | FY 2024 · Dec 31, 2024 | ¥476.88M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | ¥527.04M |
| Total Assets | FY 2024 · Dec 31, 2024 | ¥486.22M |
| Total Assets | FY 2024 · Dec 31, 2023 | ¥560.66M |
| Eps Diluted | FY 2024 · Dec 31, 2024 | −¥0.14 |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −¥0.28 |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −¥0.93 |
| Eps Basic | FY 2024 · Dec 31, 2024 | −¥0.14 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −¥0.28 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −¥0.93 |
| Net Income | FY 2024 · Dec 31, 2024 | −¥25.07M |
| Net Income | FY 2024 · Dec 31, 2023 | −¥39.92M |
| Net Income | FY 2024 · Dec 31, 2022 | −¥76.11M |
| Gross Profit | FY 2024 · Dec 31, 2024 | ¥337.79M |
| Gross Profit | FY 2024 · Dec 31, 2023 | ¥322.05M |
| Gross Profit | FY 2024 · Dec 31, 2022 | ¥355.59M |
| Cost Of Revenue | FY 2024 · Dec 31, 2024 | ¥417.89M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | ¥360.54M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | ¥314.51M |